If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Trading Update

1 Jul 2019 07:00

RNS Number : 9293D
Highlands Natural Resources PLC
01 July 2019
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

1 July 2019

 

Highlands Natural Resources plc

("Highlands" or the "Company")

 

Trading Update

 

Highlands, the London-listed natural resources company, provides the following trading update on the progress regarding its wholly owned subsidiary Zoetic and the Company's East Denver project.

 

Zoetic

 

In a timetable that has become faster than originally expected, Zoetic will now be commencing retail sales in the United Kingdom (UK) in July. Its initial shipment of products has already been despatched from the United States.

The first product lines in the UK will be CBD tinctures. These will be available in four flavours - natural, peppermint, melon and blood orange - and two strengths - 500mg and 1,000mg. Sales will be online and the Company is also in discussions with a specialist distributor with access to retail stores.

The acceleration of the UK launch means that Zoetic products will be available in the UK at the same time as they go on sale in the United States (US). This will open up revenue streams from two markets.

Considerable progress also continues to be made in the US with 26 convenience stores (previously 18) now agreeing to stock products from the Chill brand. Chill smokables should be available in all of these stores this week and the initial delivery of products has now been invoiced. In conjunction with the commencement of retail sales, Zoetic will be launching a social media campaign to build awareness of its brands in the US and UK markets.

Zoetic has also reached agreement with LeafyQuick, a specialist Chicago-based online retailer of CBD products. LeafyQuick will stock products from both the Chill and Zoetic ranges. It ships across the US but, significantly, has the capability to provide a same day delivery service in Chicago, the third largest city in the US with a population of more than 2.7 million people.

Development of Chill's follow-on products remains on track with vapes expected to be available in the US by the end of July and chew packs shortly thereafter. Chill's website (www.thechillway.com) has been live for just two weeks and has already generated considerable traffic.

 

East Denver

 

During June, two of the new wells were taken offline for workovers, during which time a gas lift was applied to assist production. The operations were completed successfully and both wells are now back on production.

This is an entirely normal occurrence for wells in the Denver region. However, the time taken for the workovers does mean that production in June has temporarily fallen below expectations. The operator is likely to take the opportunity to install artificial lifting on the remaining four wells during July, but it is anticipated this can be achieved through a rod pump. There may be some further disruption to production whilst these procedures are carried out but it is not expected to be significant.

Operating costs over recent months at the site have also been higher than initially forecast. These largely relate to the workovers and establishing the gas pipeline. Although Highlands is carried on capital expenditure, it is obliged to meet its 7.5% share of operating expenditure. These higher costs are largely one-off in nature and not expected to continue. Management has received confirmation from the operator that future monthly costs will be considerably reduced.

These recent events have meant that Highlands' objective of covering its overheads from East Denver's cashflow has not been realised over this time. However, the return to production of all wells and the reduced operating costs means that the project's financials will recover.

East Denver also remains a very valuable source of revenue for the Company as it establishes Zoetic. The nature of oil & gas wells is that they inevitably decline but, in light of the operator's policy of managing a conservative production strategy, the Board is comfortable that East Denver will continue to be a significant contributor of cashflow to the Company for some time. However, given the news set out above, the Board's expectation is that Zoetic will become an increasingly important part of Highlands' business in the coming months.

During the month of June, production at East Denver averaged approximately 2,000 Bopd and approximately 4,900 Mcfpd.

Notice of results

Highlands will be announcing its full year results for the twelve months ended 31 March 2019 on Thursday 25 July 2019. At the time of its results, the Company will provide a further update on progress on Zoetic, East Denver and all of its other projects.

Robert Price, Executive Chairman and CEO of Highlands, said: "Since we established Zoetic, it has been our stated ambition to commence product sales in the US. We are therefore delighted that this has accelerated beyond expectations and to have opened up new opportunities in a new market at the same time. To begin building a retail presence in the country of our listing is a significant step forward for Highlands.

 

"East Denver has also remained a very valuable source of revenue for Highlands. Zoetic, however, will become an increasingly important part of the business as we move forward."

 

 

**ENDS**

 

 

Enquiries

 

Highlands Natural Resources plc +1 (0) 303 322 1066

Robert Price

Nick Tulloch

 

Cantor Fitzgerald Europe +44 (0) 20 7894 7000

David Porter

Newgate Communications +44 (0) 20 3757 6880

Elisabeth Cowell highlands@newgatecomms.com

Ian Silvera

Fiona Norman

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDBLFXKQFZBBD
Date   Source Headline
25th Jun 20204:00 pmRNSHolding(s) in Company
24th Jun 20203:00 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSHolding(s) in Company
15th Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSSubscription for Equity
1st Jun 20207:00 amRNSNew Distribution Agreement and Trading Update
29th May 20207:00 amRNSFiling of Patents
27th May 20207:00 amRNSSale of DTU Interest and Kansas Nitrogen Assets
15th May 20207:00 amRNSTrading Update
11th May 20203:36 pmRNSHolding(s) in Company
6th May 20202:34 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSBoard and Strategy Changes, and Trading Update
3rd Apr 20207:00 amRNSIssue of Equity
1st Apr 20207:00 amRNSCOVID-19 Update
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSIssue of Equity
20th Mar 20207:00 amRNSCOVID-19 Update
5th Mar 20207:00 amRNSOperational update
12th Feb 20207:00 amRNSSubscription to raise £0.39 million
5th Feb 20207:00 amRNSTrading Update
23rd Dec 20197:00 amRNSInterim Results
16th Dec 20197:00 amRNSSettlement of Diversion Debt & Notice of Results
28th Nov 20197:00 amRNSResult of General Meeting
25th Nov 20197:00 amRNSTrading Update
14th Nov 20199:19 amRNSIssue of Equity
13th Nov 20192:06 pmRNSSecond Price Monitoring Extn
13th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSListing on the OTC
8th Nov 20199:01 amRNSIssue of Equity
7th Nov 20197:00 amRNSNotice of General Meeting
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
29th Oct 20194:42 pmRNSSecond Price Monitoring Extn
29th Oct 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20197:00 amRNSIssue of Shares
18th Oct 201911:05 amRNSSecond Price Monitoring Extn
18th Oct 201911:00 amRNSPrice Monitoring Extension
8th Oct 20197:00 amRNSAdoption of new share option scheme
4th Oct 20197:00 amRNSTrading Update
17th Sep 20197:00 amRNSDirectorate Change
12th Sep 201912:30 pmRNSDirector/PDMR Shareholding
9th Sep 201911:15 amRNSChange of Name
6th Sep 201910:30 amRNSDirector/PDMR Shareholding
4th Sep 201911:05 amRNSSecond Price Monitoring Extn
4th Sep 201911:00 amRNSPrice Monitoring Extension
4th Sep 20197:00 amRNSDirectorate Change
30th Aug 20194:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.